These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 34612821)
41. Epidemiology of chronic kidney disease in central and eastern europe. Rutkowski B; Król E Blood Purif; 2008; 26(4):381-5. PubMed ID: 18535372 [TBL] [Abstract][Full Text] [Related]
42. [Hepatitis C virus and chronic progressive kidney disease]. Kes P; Slavicek J Acta Med Croatica; 2009 Dec; 63(5):431-6. PubMed ID: 20198903 [TBL] [Abstract][Full Text] [Related]
43. Renal-Cerebral Pathophysiology: The Interplay Between Chronic Kidney Disease and Cerebrovascular Disease. Hanna RM; Ferrey A; Rhee CM; Kalantar-Zadeh K J Stroke Cerebrovasc Dis; 2021 Sep; 30(9):105461. PubMed ID: 33199089 [TBL] [Abstract][Full Text] [Related]
44. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. Hallan SI; Coresh J; Astor BC; Asberg A; Powe NR; Romundstad S; Hallan HA; Lydersen S; Holmen J J Am Soc Nephrol; 2006 Aug; 17(8):2275-84. PubMed ID: 16790511 [TBL] [Abstract][Full Text] [Related]
45. Plasma S100A12 and soluble receptor of advanced glycation end product levels and mortality in chronic kidney disease Stage 5 patients. Isoyama N; Leurs P; Qureshi AR; Bruchfeld A; Anderstam B; Heimburger O; Bárány P; Stenvinkel P; Lindholm B Nephrol Dial Transplant; 2015 Jan; 30(1):84-91. PubMed ID: 25074436 [TBL] [Abstract][Full Text] [Related]
46. A contemporary evaluation of carotid endarterectomy outcomes in patients with chronic kidney disease in the United States. Patel AR; Dombrovskiy VY; Vogel TR Vascular; 2017 Oct; 25(5):459-465. PubMed ID: 28181855 [TBL] [Abstract][Full Text] [Related]
47. Kidney Failure and ESRD in the Atherosclerosis Risk in Communities (ARIC) Study: Comparing Ascertainment of Treated and Untreated Kidney Failure in a Cohort Study. Rebholz CM; Coresh J; Ballew SH; McMahon B; Whelton SP; Selvin E; Grams ME Am J Kidney Dis; 2015 Aug; 66(2):231-9. PubMed ID: 25773483 [TBL] [Abstract][Full Text] [Related]
49. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis. Black C; Sharma P; Scotland G; McCullough K; McGurn D; Robertson L; Fluck N; MacLeod A; McNamee P; Prescott G; Smith C Health Technol Assess; 2010 Apr; 14(21):1-184. PubMed ID: 20441712 [TBL] [Abstract][Full Text] [Related]
50. Metabolic acidosis is associated with increased risk of adverse kidney outcomes and mortality in patients with non-dialysis dependent chronic kidney disease: an observational cohort study. Tangri N; Reaven NL; Funk SE; Ferguson TW; Collister D; Mathur V BMC Nephrol; 2021 May; 22(1):185. PubMed ID: 34011303 [TBL] [Abstract][Full Text] [Related]
51. Patient characteristics, care patterns, and outcomes of atrial fibrillation associated hospitalizations in patients with chronic kidney disease and end-stage renal disease. Kumar N; Xu H; Garg N; Pandey A; Matsouaka RA; Field ME; Turakhia MP; Piccini JP; Lewis WR; Fonarow GC Am Heart J; 2021 Dec; 242():45-60. PubMed ID: 34216572 [TBL] [Abstract][Full Text] [Related]
52. Acute Kidney Injury Recovery Pattern and Subsequent Risk of CKD: An Analysis of Veterans Health Administration Data. Heung M; Steffick DE; Zivin K; Gillespie BW; Banerjee T; Hsu CY; Powe NR; Pavkov ME; Williams DE; Saran R; Shahinian VB; Am J Kidney Dis; 2016 May; 67(5):742-52. PubMed ID: 26690912 [TBL] [Abstract][Full Text] [Related]
53. The natural history of chronic kidney disease revisited--a 72-month Mayo Health System Hypertension Clinic practice-based research network prospective report on end-stage renal disease and death rates in 100 high-risk chronic kidney disease patients: a call for circumspection. Onuigbo MA Adv Perit Dial; 2009; 25():85-8. PubMed ID: 19886324 [TBL] [Abstract][Full Text] [Related]
54. CKD stage at nephrology referral and factors influencing the risks of ESRD and death. Sud M; Tangri N; Levin A; Pintilie M; Levey AS; Naimark DM Am J Kidney Dis; 2014 Jun; 63(6):928-36. PubMed ID: 24485146 [TBL] [Abstract][Full Text] [Related]
56. Predictors of advanced chronic kidney disease and end-stage renal disease in HIV-positive persons. Ryom L; Mocroft A; Kirk O; Ross M; Reiss P; Fux CA; Morlat P; Moranne O; Smith C; El-Sadr W; Law M; Lundgren JD AIDS; 2014 Jan; 28(2):187-99. PubMed ID: 24361680 [TBL] [Abstract][Full Text] [Related]
57. [Cognitive impairment and the blood-brain barrier in chronic kidney disease: role of the uremic toxins]. Bobot M Nephrol Ther; 2023 Dec; 19(7):607-615. PubMed ID: 38059844 [TBL] [Abstract][Full Text] [Related]
58. Prevalence and risk factors for chronic kidney disease in primary health care in the southern region of New Zealand. Lloyd H; Li G; Tomlin A; Tilyard MW; Walker R; Schollum J Nephrology (Carlton); 2019 Mar; 24(3):308-315. PubMed ID: 29717528 [TBL] [Abstract][Full Text] [Related]